Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Buys Genomics Service Provider Aros

NEW YORK (GenomeWeb News) – Eurofins Scientific today announced it has bought genomics service provider Aros Applied Biotechnology for an undisclosed amount.

Based in Aarhus, Denmark, Aros services the pharmaceutical industry as well as academia and public research institutes. The deal expands Eurofins' genomics services footprint into the Nordic region.

Founded in 2000, Aros generates revenues of about €10 million ($13.2 million) and provides next-generation sequencing services to the pharma industry. Its capabilities, which also include genotyping and gene expression profiling, will complement Eurofins' current NGS services, which are offered through its Eurofins MWG Operon business.

The deal allows Eurofins to expand its share of the high-growth NGS market targeted to pharma "by leveraging its increased scale," it said, adding that Aros will now have access to an expanded portfolio of genomic services.

According to Aros' website, the company provides sample banking, extraction of molecules, microarray analysis, PCR-based testing, and bioinformatics services, as well as NGS services. The platforms it uses include those from Affymetrix, Illumina, Agilent Technologies, Qiagen, Fluidigm. and Life Technologies' Applied Biosystems.

"Aros is an excellent strategic fit with Eurofins' genomic services business," Eurofins CEO Gilles Martin said in a statement. "It expands our geographical footprint for our genomics offering, and their competence is entirely consistent with our focus on high-quality next-generation sequencing. We remain committed to strengthening our market position in genomic services, as we believe that technological advancements in sequencing equipment will eventually enable mass application of NGS across industries."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.